"10.1371_journal.pone.0048387","plos one","2012-11-14T00:00:00Z","Kousei Ohshima; Masaki Mogi; Fei Jing; Jun Iwanami; Kana Tsukuda; Li-Juan Min; Akiyoshi Ogimoto; Björn Dahlöf; Ulrike M Steckelings; Tomas Unger; Jitsuo Higaki; Masatsugu Horiuchi","Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University, Graduate School of Medicine, Tohon, Ehime, Japan; Department of Integrated Medicine and Informatics, Ehime University, Graduate School of Medicine, Tohon, Ehime, Japan; Department of Medicine, Sahlgrenska University Hospital/Östra, University of Gothenburg, Gothenburg, Sweden; Center for Cardiovascular Research, Institute of Pharmacology, Charité University Medicine, Berlin, Germany; CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands","Conceived and designed the experiments: MH. Performed the experiments: KO FJ JI KT LM. Analyzed the data: KO. Wrote the paper: KO MM MH. Read and approved the manuscript: MM AO BD US TU JH MH.","TU has modest interest in Vicore Pharma, and BD and TU have received speaker and consulting fees from Vicore Pharma. BD also has significant interest in Mintage Scientific, the owner of Vicore Pharma. The Compound 21 used in this study was provided by Vicore Pharma. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2012","11","Kousei Ohshima","KO",12,TRUE,1,5,1,3,TRUE,TRUE,FALSE,0,NA,FALSE
